WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC

RegulatoryapprovedXpert® Hemorrhagic Fever Panel TestPositive

AI Analysis

Summary

Cepheid announced WHO Emergency Use Listing approval for its Xpert Hemorrhagic Fever Panel Test to support Ebola outbreak response in the Democratic Republic of Congo. The GeneXpert Dx system's existing footprint across Africa enables rapid deployment of decentralized molecular testing.

Outcome Details

WHO Emergency Use Listing granted for Xpert Hemorrhagic Fever Panel Test

Importance:7/10

Sentiment:

0.80

regulatory approvalWHOemergency use listingmolecular diagnosticsinfectious diseaseoutbreak responseAfrica

Related Companies

$MOLN $RTSL

Read the original article

Published by PR Newswire Biotech on September 3, 2026 4:00 PM

Read Original